Wedbush Downgrades Avrobio to Neutral, Announces $2 Price Target
Portfolio Pulse from richadhand@benzinga.com
Wedbush analyst David Nierengarten has downgraded Avrobio (NASDAQ:AVRO) from Outperform to Neutral and set a price target of $2.

July 12, 2023 | 3:40 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Avrobio has been downgraded from Outperform to Neutral by Wedbush, with a new price target of $2.
The downgrade from Outperform to Neutral by a well-known analyst firm like Wedbush is likely to negatively impact investor sentiment towards Avrobio. The new price target of $2 also suggests a potential downside, which could put further pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100